Liontrust Investment Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.77M Sell
232,916
-207,212
-47% -$8.67M 0.13% 103
2025
Q4
$19.9M Buy
440,128
+142,088
+48% +$5.2M 0.3% 77
2025
Q3
$9.08M Sell
298,040
-20,244
-6% -$622K 0.13% 111
2025
Q2
$9.36M Buy
318,284
+142,629
+81% +$4.27M 0.13% 105
2025
Q1
$6.14M Buy
175,655
+11,981
+7% +$475K 0.1% 119
2024
Q4
$7.29M Buy
163,674
+13,464
+9% +$605K 0.11% 111
2024
Q3
$4.07M Hold
150,210
0.06% 128
2024
Q2
$4.07M Buy
+150,210
New +$4.35M 0.06% 128

Other funds holding OMCL

Liontrust Investment Partners's OMCL Position: Q1 2026 in Review

Liontrust Investment Partners reduced its Omnicell (OMCL) stake by 47% in Q1 2026, selling an estimated $8.67M and leaving 232,916 shares worth $7.77M. The position accounts for 0.13% of the portfolio, ranked #103.

Liontrust Investment Partners first reported a position in OMCL in Q2 2024 and has held it in 8 quarters since. The position peaked at $19.9M in Q4 2025. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Liontrust Investment Partners held 232,916 shares of Omnicell worth $7.77M as of Q1 2026.
  • Liontrust Investment Partners sold 207,212 Omnicell shares in Q1 2026, an estimated $8.67M.
  • Omnicell made up 0.13% of Liontrust Investment Partners's portfolio in Q1 2026, its #103 holding.
  • Liontrust Investment Partners first reported a position in Omnicell in Q2 2024 and has held it in 8 quarters since.
  • Liontrust Investment Partners's Omnicell position peaked at $19.9M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Liontrust Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.